Park Medi World IPO GMP Today: Complete Analysis of Subscription and Allotment Details
Park Medi World IPO GMP Today: Complete Analysis of Subscription and Allotment Details
Park Medi World IPO GMP today has dropped significantly on the final day of subscription. The hospital chain’s public offer closed on December 12, 2025 with full subscription after a slow start. Investors are now tracking the grey market premium and allotment chances as the listing approaches next week.
The IPO worth 920 crore rupees saw strong participation from non institutional investors and qualified institutional buyers on day 3. However, the falling GMP has raised questions about potential listing gains for retail investors who applied during the three day bidding period.
The grey market premium dropped from 33 rupees during pre open to just 3 to 12 rupees on the closing day. This sharp fall of nearly 70 percent reflects cautious market sentiment amid broader weakness in secondary markets.
Park Medi World operates 14 NABH accredited hospitals across North India with total bed capacity of 3000 as of March 2025. The company is second largest private hospital chain in North India and largest in Haryana state. The IPO proceeds will be used for debt repayment, capital expenditure and general corporate purposes.
Key Takeaways
- Park Medi World IPO subscribed 7.34 to 8.03 times overall by closing on December 12, 2025
- Grey market premium dropped sharply from 33 rupees to 3 to 12 rupees indicating muted listing gains
- IPO allotment date is December 15, 2025 and listing scheduled for December 17, 2025
- Retail category subscribed 2 to 3 times while NII achieved 11 to 12 times subscription
- QIB portion saw late surge with 5 to 12 times booking on final day
- Company operates 14 hospitals with 3000 beds across Haryana, Punjab, Delhi NCR, Rajasthan and UP
- IPO priced at 154 to 162 rupees per share with minimum application of 92 shares
Also Read: NephroPlus IPO GMP Today: Final Day Subscription Status and Listing Preview
Park Medi World IPO Subscription Status
The subscription numbers improved dramatically on day 3 after a weak opening. Retail investors showed steady interest with 2.66 to 3 times subscription while non institutional investors led the charge at 12 times oversubscription. The qualified institutional buyers category picked up momentum late and closed at 5 to 12 times depending on final data. Total bids received were around 5.67 crore shares against 4.18 crore shares offered.
Compared to peer Nephrocare Health IPO which closed at 12 times subscription on the same day, Park Medi World showed balanced but less explosive demand. The slow start on day 1 with only 0.52 times subscription reflected investor caution.
Market volatility and broader Nifty weakness of 0.5 percent during the week dampened enthusiasm. Retail participation remained stable throughout indicating confidence in long term prospects despite subdued short term outlook.
Grey Market Premium Analysis
Park Medi World IPO GMP today stands at just 2 to 7 percent over upper price band. The premium started at 20 percent on December 8 before subscription opened. On day 1 it cooled to 13 to 14 percent and further dropped to 5 to 9 percent on day 2. The final day saw sharp correction with GMP falling to 3 to 14 rupees intraday before settling lower.
This indicates expected listing price of 166 to 170 rupees against issue price of 162 rupees. The modest 2 to 5 percent listing pop is much lower than initial expectations. Grey market operators quote kostak rate of 200 to 300 rupees for selling bids before allotment. However subject to sauda activity remains minimal showing limited interest in post allotment trades.
The falling GMP mirrors broader cooling in healthcare IPO space. Investors who hoped for strong listing gains may be disappointed. Market experts suggest GMP near zero makes this unsuitable for short term flipping. Those applying should have long term investment horizon of 1 to 2 years to benefit from company’s expansion plans.
Company Fundamentals and Valuation
Park Medi World reported revenue of 1338 crore rupees in FY25, up 22 percent year on year. Net profit stood at 213 crore rupees compared to 152 crore rupees in FY24. The company added 700 beds between FY23 and FY25 through organic growth and acquisitions. Current bed occupancy is around 68 percent with ongoing projects in Ambala, Panchkula, Rohtak, New Delhi, Gorakhpur and Kanpur.
The IPO is priced at 32.8 times FY25 price to earnings ratio. Analysts like Anand Rathi consider this fair valuation given strong fundamentals. Listed peers like Apollo and Max Healthcare trade at 45 to 100 times P/E making Park Medi World cheaper entry point. EBITDA margin of 26.7 percent and return on net worth of 20.1 percent show healthy profitability.
The company benefits from rising lifestyle diseases, aging population and government schemes like PMJAY. As Haryana’s largest hospital chain, it has strong regional presence. The fresh issue of 770 crore rupees will reduce debt of 800 crore rupees and fund capacity expansion. Six new hospitals are planned by March 2028 taking total beds to 4900.
Allotment and Listing Details
Park Medi World IPO allotment will be finalized on December 15, 2025. Investors can check status on NSE website or registrar KFin Technologies portal using PAN number and application number. The shares will list on BSE and NSE on December 17, 2025. Refunds for non allotted applicants will be processed by December 16.
Retail investors face tough allotment odds with 1 in 3 chance due to 2.66 times subscription. Non institutional investors have even lower odds at 1 in 11 given 12 times oversubscription. QIB applicants may get better allocation with 5 to 12 times booking. Anchor investors already received shares worth 276 crore rupees on December 9 at upper band price.
Investment Recommendation
Short term traders should avoid this IPO as low GMP indicates limited listing gains. The expected 2 to 5 percent pop barely covers transaction costs. Weak market sentiment and modest subscription compared to peers suggest muted debut. Those who applied hoping for quick flip may consider selling allotted shares on listing day.
Long term investors can consider Park Medi World for healthcare sector exposure. The company has solid fundamentals with 22 percent revenue growth and strong profit margins. Expansion into tier 2 and tier 3 cities provides growth runway. Valuations are reasonable compared to listed hospital chains. Sector is expected to grow at 12 to 15 percent annually reaching 9.4 to 9.8 trillion rupees by FY28.
Key risks include dependence on single state Haryana, execution challenges in capacity addition, and high debt before IPO proceeds. Competition from established players and reliance on government health schemes add uncertainty. Investors should evaluate these factors based on risk appetite and investment horizon before taking final decision.
Tags: Park Medi World IPO, IPO GMP today, healthcare IPO, hospital chain IPO, IPO subscription status, IPO allotment date, North India hospitals
Related Posts :
Share This Post